Trials / Sponsors / Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hype Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | 2025-10-06 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hyp Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | 2021-06-14 |
| Completed | Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due Ischemia, Coronary Artery Disease | Phase 2 | 2021-04-23 |
| Completed | IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpE Type 2 Diabetes, Diabetic Cardiomyopathies, HFpEF - Heart Failure With Preserved Ejection Fraction | Phase 2 | 2021-04-21 |
| Withdrawn | A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina Refractory Angina | Phase 2 | 2020-05-01 |